718
Views
92
CrossRef citations to date
0
Altmetric
Research Article

Neuro-ophthalmic Sarcoidosis: The University of Iowa Experience

, , , , &
Pages 157-168 | Published online: 02 Jul 2009

REFERENCES

  • Longscope W, Frieman D. A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 1952; 31: 1–142
  • Joint Statement of the American Thoracic Society (ATS). The European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736–55
  • James G D. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York 1994
  • Cummings M M, Dunner E, Schmidt H J, et al. Concepts of epidemiology of sarcoidosis: preliminary report of 1,194 cases reviewed with special reference to geographic ecology. Postgrad Med 1956; 19: 437–46
  • Ricker W, Clark M. Sarcoidosis: a clinicopathological review of three hundred cases including 22 autopsies. Am J Clin Pathol 1949; 19: 725–49
  • Rybicki B A, Major M, Popovich J, Jr, Maliarik M J, Iannuzzi M C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234–41
  • Maycock R I, Bertrand P, Morrison C E, Scott J H. Manifestations of sarcoidosis: analysis of 145 patients with review of nine series selected from the literature. Am J Med 1963; 35: 67–89
  • Siltzbach L E, James D G, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57: 847–52
  • Keller A Z. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971; 94: 222–230
  • McNicol M W, Luce P J. Sarcoidosis in a racially mixed community. J R Coll Physicians Lond 1985; 19: 179–83
  • Frohman L P, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuro-Ophthalmol 2001; 21: 132–37
  • Frohman L P, Guirgis M, Turbin R E, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol 2003; 23: 187–9
  • Heuser K, Kerty E. Neuro-ophthalmological findings in sarcoidosis. Acta Ophthalmol Scand 2004; 82: 723–9
  • Lamirel C, Badelon I, Gout O, et al. Neuro-ophthalmologic initial presentation of sarcoidosis. J Fr Ophtalmol 2006; 29: 241–9
  • United States Census Bureau. 2001 Profiles of General Demographic Characteristics: 2000 Census of Population and Housing, http://factfinder.census.gov Available at. Accessed September 21, 2007
  • United States Census Bureau. 2006 American Community Survey, http://factfinder.census.gov Available at. Accessed September 21, 2007
  • Fanburg B L. Sarcoidosis and Other Granulomatous Diseases of the Lung. Marcel Dekker, New York 1983; 37–75
  • Maycock R I, Bertrand P, Morrison C E, Scott J H. Manifestations of sarcoidosis: analysis of 145 patients with review of nine series selected from the literature. Am J Med 1963; 35: 67–89
  • Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977; 87: 336–45
  • Stern B J, Krumholz A, Johns C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42: 909–17
  • Gullapalli D, Phillips L H. Neurologic manifestation of sarcoidosis. Neurol Clin 2002; 20: 59–83
  • Christoforidis G A, Spickler E M, Recio M V, et al. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol 1999; 20: 655–9
  • Hayes W S, Sherman J L, Stern B J, et al. MR and CT evaluation of intracranial sarcoidosis. Am J Roentgenol 1987; 149: 1043–9
  • Zajicek J P, Scolding N J, Foster O, et al. Central nervous system sarcoidosis-diagnosis and management. QJM 1999; 92: 103–17
  • Oksanen V. Neurosarcoidosis: clinical presentation and course in 50 patients. Acta Neurol Scand 1986; 73: 283–90
  • Chapelon C, Ziza J M, Piette J C, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicin 1990; 69: 261–76
  • Spencer T S, Campellone J V, et al. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 2005; 34: 649–61
  • Oksanen V, Grönhagen-Riska C, Fyhrquist F, Somer H. Systemic manifestations and enzyme studies in sarcoidosis with neurologic involvement. Acta Med Scand 1985; 218: 123–7
  • Sharma O P. Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 1997; 112: 220–8
  • Ferriby D, de Seze J, Stojkovic T, et al. Long-term follow-up of neurosarcoidosis. Neurology 2001; 57: 927–9
  • Lower E E, Broderick J P, Brott T G, Baughman R P. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157: 1864–8
  • Wiederholt W C, Siekert R G. Neurological manifestation of sarcoidosis. Neurology 1965; 15: 1147–54
  • Kellinghaus C, Schilling M, Lüdemann P. Neurosarcoidosis: clinical experience and diagnostic pitfalls. Eur Neurol 2004; 51: 84–8
  • Allen R K, Sellars R E, Sandstrom P A. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 118–25
  • Jabs D A, Johns C J. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986; 102: 297–301
  • Beardsley T L, Brown S V, Sydnor C F, et al. Eleven cases of sarcoidosis of the optic nerve. Am J Ophthalmol 1984; 97: 62–77
  • Lynch J P. Neurosarcoidosis: how good are the diagnostic tests?. J Neuro-ophthalmol 2003; 23: 187–9
  • Carmody R F, Mafee M F, Goodwin J A, et al. Orbital and optic pathway sarcoidosis: MR findings. Am J Neuroradiol. 1994; 15: 775–83
  • Marangoni S, Argentiero V, Tavolato B. Neurosarcoidosis: clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol 2006; 253: 488–95
  • Lynch J P, 3rd, Ma Y L, Koss M N, White E S. Pulmonary sarcoidosis. Semin Respir Crit Care Med. 2007; 28: 53–74
  • Stern B J, Corbett J. Neuro-ophthalmologic manifestations of sarcoidosis. Curr Treat Options Neurol 2007; 9: 63–71

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.